Brief: Optinose Submits Supplemental New Drug Application For Xhance Label Expansion
21/02/2023 12:11
Feb 21 (Reuters) - OptiNose Inc OPTN.O :
* OPTINOSE SUBMITS SUPPLEMENTAL NEW DRUG APPLICATION FOR
XHANCE
LABEL EXPANSION
Source text for Eikon: ID:nGNXP7gYs
Further company coverage: OPTN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on OptiNose
See all newsOptiNose Inc reports results for the quarter ended March 31 - Earnings Summary
OptiNose Inc expected to post a loss of 74 cents a share - Earnings Preview
Brief: OptiNose Q4 Income From Operations USD 354 Thousand
U.S. RESEARCH ROUNDUP-Darden Restaurants, Nike, Optinose
U.S. STOCKS ON THE MOVE-Accenture, Nike, FedEx